Ojeda LMC

Language: Spanish
References: 20
Page: 182-189
PDF size: 152.21 Kb.

ABSTRACT

Spinocerebellar ataxia (SCA) are a heterogeneous group of neurodegenerative diseases with autosomal dominant inheritance. In various subtypes of SCA, neuropsychiatric manifestations have been described as affective disorders, anxiety or psychotic and cognitive impairment. So far no study of cognitive and neuropsychiatric manifestations in SCA in Mexican population and few studies in the international literature that describe in detail their characteristics. Objective: To describe neuropsychiatric and cognitive manifestations in patients with ACS in the Mexican population, assess the relationship between them and other signs extracerebellar by analyzing clinical, neuropsychological, imaging studies and neurophysiology of patients treated at the National Institute of Neurology and Neurosurgery. Results: A high frequency of neuropsychiatric manifestations (70%), mainly for depressive syndromes (39%) and mood symptoms no relationship between the severity of ataxia and presence thereof was found. In 39% of patients cognitive impairment is identified, principally involvement of attentional, executive functions and calculus. Conclusion: These findings show that neuropsychiatric symptoms are common in patients with ACS in the Mexican population, as well as cognitive impairment. Detection and treatment can improve the quality of life of these patients and promote the premotor detection of those affected.

REFERENCES

1. Alonso E, Martínez-Ruano L, De Biase I, Mader C, Ochoa A, Yescas P, et al. Disctinct distribution of autosomal dominant spinocerebellar ataxia in the Mexican population. Mov Disord 2007; May 15;22(7):1050-3.

2. Benton CS, de Silva R, Rutledge SL, Bohlega S, Ashizawa T, Zoghbi HY. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurol 1998;51:1081-6.

3. Bürk K, Globas C, Bösch S, Klockgether T, Zühlke C, Daum I, et al. Cognitive deficits in spinocerebellar ataxia type 1, 2 and 3. J Neurol 2003 Feb;250(2):207-11.

4. Chen KH, Lin CH, Wu RM. Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2. BMJ Case Rep 2012 Mar 20;2012. pii: bcr1020115061. doi: 10.1136/ bcr.10.2011.5061.

5. Kawai Y, Suenaga M, Watanabe H, Sobue G.Cognitive impairment in spinocerebellar degeneration. Eur Neurol 2009;61(5):257-68.

6. Kawai Y, Takeda A, Abe Y, Washimi Y, Tanaka F, Sobue G. Cognitive impairments in Machado-Joseph disease. Arch Neurol 2004;61:1757-60.

7. Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum 2010 Sep;9(3):433-42.

8. Kobayashi H, Abe K, Matsuura T, Ikeda Y, Hitomi T, Akechi Y, et al. Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of Spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet 2011;89:121-30.

9. Koziol LF, Budding D, Andreasen N, D’Arrigo S, Bulgheroni S, Imamizu H, et al. Consensus Paper: the cerebellum’s role in movement and cognition. Cerebellum 2013; doi:10.1007/ s12311-013-0511-x.

10. Liszewski CM, O’Hearn E, Leroi I, Gourley L, Ross Ca, Margolis RL. Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration. J Neuropsychiatry Clin Neurosci 2004;16(1): 109-12.

11. Mascalchi M. Spinocerebellar ataxias. Neurol Sci 2008; 29:S311-S3.

12. Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, Alonso E. Clinic al and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 2001; 50:234-9.

13. Reynaldo-Armiñán RD, Reynaldo-Hernández R, Paneque- Herrera M, Prieto-Avila L, Pérez- Ruiz E. Trastornos mentales en pacientes con ataxia espinocerebelosa tipo 2 cubana. Rev Neurol 2002 Nov 1-15;35(9):818-21.

14. Rottnek M, Riggio S, Byne W, Sano M, Margolis RL, Walker RH. Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis? Am J Psychiatry 2008 Aug;165(8): 964-7.

15. Schiffer RB. Depression in neurological practice: diagnosis, treatment, implications. Semin Neurol 2009 Jul;29(3):220- 33.

16. Schmahman JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain 1998; 121:561-79.

17. Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16:367-78.

18. Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum-insights from the clinic. Cerebellum 2007;6(3):254-67.

19. Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, et al. Depression comorbidity in spinocerebellar ataxia. Mov Disord 2011; Apr;26(5):870-6.

20. Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, Berciano J, Boesch S, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurol 2006;66: 1717-20.